@misc{indiciae68fedfd73ef4,
  title = {A First-in-Japanese Phase 1, Double-Blind, Placebo-Controlled, Parallel-Cohort Study of Sefaxersen, an Antisense Oligonucleotide Targeting Complement Factor B, in Healthy Participants.},
  author = {Takakazu Sato and Hiroyuki Fukase and Takaaki Ishida and Arisa Karasawa},
  year = {2026},
  doi = {10.1002/cpdd.70097},
  url = {https://pubmed.ncbi.nlm.nih.gov/42713733/},
  note = {Source identifier: 42713733}
}